Version 5.4
Bos taurus Protein: AMOTL1
Summary
InnateDB Protein IDBP-680897.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol AMOTL1
Protein Name angiomotin like 1
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000025212
InnateDB Gene IDBG-629466 (AMOTL1)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 5 interaction(s) predicted by orthology.
Predicted by orthology
Total 5 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005515 protein binding
GO:0042802 identical protein binding
Biological Process
GO:0003365 establishment of cell polarity involved in ameboidal cell migration
GO:0016055 Wnt signaling pathway
GO:0035329 hippo signaling
GO:0043536 positive regulation of blood vessel endothelial cell migration
Cellular Component
GO:0005737 cytoplasm
GO:0005923 tight junction
GO:0008180 COP9 signalosome
GO:0016324 apical plasma membrane
GO:0030027 lamellipodium
GO:0030054 cell junction
GO:0031410 cytoplasmic vesicle
Protein Structure and Domains
PDB ID
InterPro IPR009114 Angiomotin
IPR024646 Angiomotin, C-terminal
PFAM PF12240
PRINTS PR01807
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt E1BEQ5
PhosphoSite PhosphoSite-
TrEMBL
UniProt Splice Variant
Entrez Gene 541209
UniGene Bt.56671
RefSeq XP_002693006
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02040143
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca